Global Ophthalmic Ultrasound Imaging System Market Size, Share, Growth and Forecast 2028

Ophthalmic Ultrasound Imaging System Industry Prospective:

The global ophthalmic ultrasound imaging system market was nearly USD 3,953.2 million in 2021 and is anticipated to reach around USD 6,014.21 million by 2028, with a compound annual growth rate (CAGR) of around 8.4 percent over the forecast period. The report analyzes the ophthalmic ultrasound imaging system market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the ophthalmic ultrasound imaging system market.

Request Free Sample

Ophthalmic Ultrasound Imaging System Market: Overview

The ophthalmic ultrasound imaging system is a form of non-invasive viewing technology that is more convenient. Ophthalmic ultrasound imaging devices allow for the imaging of anatomy and disease in the eye's frontal and posterior segments. A transducer probe is put in a medium in ophthalmic ultrasound imaging systems, which creates waves of a certain frequency that impact internal structures in the eye.

The waves collected by the transducer, as well as the voltages that arise, are intensified and analyzed to create pictures. Different sorts of modalities are employed according to the ocular disease or disorder.

Request Free Sample

COVID-19 Impact:

The pandemic of COVID-19 had a huge influence on the market. Routine healthcare operations were avoided to protect patients from getting the virus. Also, ophthalmology procedures were disproportionately affected, resulting in a decline in routine clinical treatment, which in turn lowered product demand. This resulted in a significant drop in income and the temporary or permanent closure of single ophthalmology practices.

Ophthalmic Ultrasound Imaging System Market: Growth Drivers

The growing prevalence of ocular disorders and diseases is anticipated to drive the market growth

The rising prevalence of eye diseases such as angle trauma, neoplasms, ciliary body cysts, cataract, glaucoma, and uncorrected refractive errors is propelling the growth of the global ophthalmic ultrasound imaging system market. Eye diseases have risen as a real concern to populations in many developing and developed economies. Diabetic retinopathy has been added to the priority list since the prevalence of diabetes has increased in several nations. According to recent research done by the CDC, diabetic retinopathy affects about one-third of persons over the age of 40 who have diabetes. Diabetic retinopathy affected 4.2 million individuals, with 655,000 of them having vision-threatening diabetic retinopathy.

Also, due to problems in early identification and the frequent need for life-long therapies, glaucoma, a long-known eye condition, remains on the public health agenda. Such a huge burden of disease has led to the increasing use of ophthalmic ultrasound imaging systems thereby boosting the growth of the market. Further, the use of portable imaging systems is also fostering the growth of the market.

Ophthalmic Ultrasound Imaging System Market: Restraints

Increase in adoption of alternative diagnostic tools may hamper the market growth

The market for ophthalmic ultrasound imaging systems is projected to be constrained by the development and use of other diagnostic technologies. Optical biometry devices that use partial coherence interferometry are preferred by ophthalmic surgeons and practitioners. Unlike ophthalmic ultrasound imaging systems, which need extensive training for examiners to minimize handling mistakes, optical biometry devices (such as IOL Master 700 and Carl Zeiss Meditech's IOL Master 500) are quick and simple to use and have been shown to be more accurate.

In addition to this, the cost of a high-tech ophthalmology system is projected to stifle the market for ophthalmic ultrasound imaging systems. The high price of these devices has a negative impact on the primary clients of these devices, such as hospitals and specialist clinics, stifling the growth of the market.

Ophthalmic Ultrasound Imaging System Market: Opportunities

An increase in clinical applications and advancing technologies is expected to fuel the market growth during the forecast period.

With the development of minimally invasive operations, new technological platforms provide better imaging reliability, precision, safety, and reduced post-operative discomfort. To meet the needs and demands of patients, numerous manufacturers are substantially investing in the development of breakthrough diagnostic and surgical platforms.

As a consequence, various ophthalmology gadgets have expanded in popularity and acceptability, propelling the global ophthalmic ultrasound imaging system market further.

Ophthalmic Ultrasound Imaging System Market: Challenges

Low adoption of ophthalmic ultrasound imaging systems in underdeveloped countries may be a challenge for market growth

The market for ophthalmic ultrasound imaging systems may face challenges due to a lack of knowledge and awareness in underdeveloped nations. This is mainly attributed to less-developed healthcare infrastructure, low disposable income, and less spending on healthcare.

In addition to this, due to the strict rules of regulatory bodies such as the Japanese FDA, the European CE Mark, and the US Food and Drug Administration (FDA), the approval process takes a long time. This also acts as a challenge to market growth.

Ophthalmic Ultrasound Imaging System Market: Report Scope

Ophthalmic Ultrasound Imaging System Market: Segmentation

The global ophthalmic ultrasound imaging system market is divided based on mobility, product, end-use, and region.

Based on mobility, the global market is categorized into portable and standalone.

Based on The product, segment is classified into the combined scan, A-scan, B-scan, Ultrasound Biomicroscopy (UBM), and pachymeter.

Based on The end-user, segment is characterized by ambulatory surgical centers, hospitals, ophthalmic clinics, and others.

Recent Developments

• In April 2022, Quantel Medical introduced two new diagnostic ultrasound probes to their Aviso™ platform, which is their premier ultrasound platform. The novel probes enhance the diagnosis of ocular disorders in the posterior and anterior segments.
• In March 2019, FDA approved ABSolu, Quantel Medical's newest A/B/S ultrasound technology. To deliver high-quality, standardized ophthalmic ultrasound imaging, the A/B/S/UBM ultrasound platform combines technologies including a unique 5-ring annular technology high-definition screen, combined motion sensors, and a 20MHz B probe.

Ophthalmic Ultrasound Imaging System Market: Regional Landscape

North America is likely to lead the market for ophthalmic ultrasound imaging systems

Over the anticipated period, North America is likely to dominate the global ophthalmic ultrasound imaging system market. This is attributed to improved healthcare infrastructure and increased healthcare spending. Furthermore, the market is expected to be boosted by the existence of a significant number of key players and suppliers. The existence of a large senior population in

Europe would make it a lucrative market for ophthalmic ultrasound imaging systems. One of the primary reasons driving market growth in this region is the presence of various ophthalmic associations, including the European Society of Ophthalmology (ESC) and the European Society of Cataract and Refracting Surgeons, which encourage the practice and research of contemporary ophthalmology. With the highest rates of glaucoma and uncorrected refractive errors in the world, Asia Pacific might be a lucrative market for ophthalmic ultrasound imaging systems in the forthcoming years.

Ophthalmic Ultrasound Imaging System Market: Competitive Landscape

Some of the major players operating in the global ophthalmic ultrasound imaging system market include;

• Escalon Medical Corp
• Optos
• Quantel Medical
• NIDEK CO. Ltd.
• Halma plc
• Carl Zeiss Meditech
• Ellex
• MicroMedical Devices
• Appasamy Associates

The global ophthalmic ultrasound imaging system market is segmented as follows:

By Mobility

• Portable
• Standalone

By Product

• Combined Scan
• A-Scan
• B-Scan
• Ultrasound Bio-microscopy (UBM)
• Pachymeter

By End-Use

• Ambulatory Surgical Centers
• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa